Clinical Trials Logo

Esophagogastric Junction Cancer clinical trials

View clinical trials related to Esophagogastric Junction Cancer.

Filter by:

NCT ID: NCT02979691 Completed - Esophagus Cancer Clinical Trials

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

Start date: October 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Ratiotherapy alone is the current standard treatment for elderly esophageal or esophagogastric cancer in China. And Little is known about chemoradiotherapy (CRT) in elderly patients. This study aimed to assess the efficiency and safety of simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) with S1 based SIB-IMRT followed by adjuvant chemotherapy with S1 in in elderly (age ≥70 years) esophageal or esophagogastric cancer patients

NCT ID: NCT01248403 Completed - Clinical trials for Advanced Gastric Cancer

A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy

AIO-STO-0111
Start date: October 2011
Phase: Phase 3
Study type: Interventional

Adult patients with gastric carcinoma which has progressed after initial treatment with a fluoropyrimidines-containing regimen will be treated with paclitaxel plus RAD001 or plus placebo. The hypothesis is that patients with RAD001 have significantly prolonged overall survival compared to patients who are treated with paclitaxel alone.